Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary Hyperparathyroidism: A post hoc Analysis of a Randomized Trial

Hirotaka Komaba, Seigo Akari, Yoshiyuki Ono, Masafumi Fukagawa

Open source

DOI
10.1159/000548738
Published
2025-10-10
Container
American Journal of Nephrology
Publisher
S. Karger AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000548738,
  title = {Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary Hyperparathyroidism: A post hoc Analysis of a Randomized Trial},
  author = {Hirotaka Komaba and Seigo Akari and Yoshiyuki Ono and Masafumi Fukagawa},
  year = {2025},
  journal = {American Journal of Nephrology},
  doi = {10.1159/000548738},
  url = {https://doi.org/10.1159/000548738}
}

RIS

TY  - JOUR
TI  - Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary Hyperparathyroidism: A post hoc Analysis of a Randomized Trial
AU  - Hirotaka Komaba
AU  - Seigo Akari
AU  - Yoshiyuki Ono
AU  - Masafumi Fukagawa
PY  - 2025
JO  - American Journal of Nephrology
DO  - 10.1159/000548738
UR  - https://doi.org/10.1159/000548738
ER  - 

APA

Komaba, H., Akari, S., Ono, Y., & Fukagawa, M. (2025). Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary Hyperparathyroidism: A post hoc Analysis of a Randomized Trial. American Journal of Nephrology. https://doi.org/10.1159/000548738

Source records